# Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/preemptive-lamivudine-therapy-based-on-hbv-dna-level-in-hbsag-positive-kidney/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tak Mao Chan,Guo Fang,Colin Tang,Ignatius K.P. Cheng,Kar Neng Lai,Stephen Ho |
| Citations | 161 |
| DOI | 10.1053/jhep.2002.36156 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1053/jhep.2002.36156 |
| OpenAlex ID | https://openalex.org/W2010857849 |
| PMID | 12395336 |
| Type | article |
| Year | 2002 |

## Paper authors

- [Tak Mao Chan](https://scholariq.org/researchers/tak-mao-chan/)
- [Colin Tang](https://scholariq.org/researchers/colin-tang/)

## Paper primary topic

- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)

## Paper topics

- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.